Democrats in the Senate and House introduced companion bills Wednesday that would permit generic drug companies to update warning information about the drugs they manufacture, a change that could allow patients to sue the companies for failing to warn about the risks of taking their drugs. The New York Times has the details here.
UPDATE: 4/20/12: the FDA law blog has more on this story here.
No comments:
Post a Comment